Previous 10 | Next 10 |
REDWOOD CITY, Calif. , Aug. 28, 2019 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain conditions, today announced that it has completed patient enrollment in its prospect...
REDWOOD CITY, Calif. , Aug. 23, 2019 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, today announced the Company will be participating in the Morgan Stanley 17 th ...
August 12, 2019 Palm Beach, FL – August 12, 2019 – Cellulite has been the bane of many women (and men too) for years, but the market is expected to rise significantly through 2026, industry reports project. One report said that the global cellulite treatment market...
Nevro Corp. (NVRO) Q2 2019 Earnings Conference Call August 8, 2019 4:30 PM ET Company Participants Juliet Cunningham – Vice President-Investor Relations Keith Grossman – Chairman, Chief Executive Officer and President Andrew Galligan – Chief Financial Officer...
Nevro (NYSE: NVRO ): Q2 GAAP EPS of -$0.91 beats by $0.06 . More news on: Nevro Corp., Earnings news and commentary, Healthcare stocks news, Read more ...
REDWOOD CITY, Calif. , Aug. 8, 2019 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, today reported financial results for the second quarter ended June 30, 2019 . Revenue...
REDWOOD CITY, Calif. , July 25, 2019 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative evidence-based solutions for the treatment of chronic pain, today announced that U.S. District Judge Colm Connolly , in the District of Delaware , ...
REDWOOD CITY, Calif. , July 15, 2019 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, today announced that the Company will release its financial results for the second ...
Nevro (NYSE: NVRO ) appoints Ms. Niamh Pellegrini as Chief Commercial Officer and Ms. Lori Ciano as Chief Human Resources Officer. Both will report directly to D. Keith Grossman, Chairman, CEO and President. More news on: Nevro Corp., Healthcare stocks news, Read more ...
REDWOOD CITY, Calif. , June 25, 2019 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, today announced the appointments of two senior executives to the Company's leadersh...
News, Short Squeeze, Breakout and More Instantly...
Nevro to Report Second-Quarter 2024 Financial Results and Host Earnings Conference Call on August 6, 2024 PR Newswire REDWOOD CITY, Calif. , July 9, 2024 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company delivering comprehensive, life-chan...
Nevro to Present at Truist Securities MedTech Conference PR Newswire REDWOOD CITY, Calif. , June 11 , 2024 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chr...
Nevro Announces New Employee Inducement Grants Under NYSE Rule 303A.08 PR Newswire REDWOOD CITY, Calif. , May 24, 2024 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the trea...